 | | Vol. 12.36 – 17 September, 2020 |
| |
|
|
|
Scientists demonstrated that amniotic fluid stem cells and extracellular vesicles attenuated necrotizing enterocolitis intestinal injury by activating the Wnt signaling pathway.
[Cell Death & Disease] |
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers extensively compared the physiological functions of human Wharton’s jelly-derived mesenchymal stem cells in a xeno-free medium and a medium containing 10% fetal bovine serum.
[Journal of Clinical Medicine] |
|
|
|
| Investigators studied the effect of allogeneic umbilical cord mesenchymal stem cell transplantation on the structure and function of the thymus in aged C57 mice and provided a new method for the treatment of senile thymic atrophy.
[Aging] |
|
|
|
| The authors report that TNFSF15, a member of the tumor necrosis factor superfamily, promoted the expansion of human umbilical cord blood‐derived hematopoietic stem cells.
[Journal of Cellular and Molecular Medicine] |
|
|
|
| CD73-positive population from various tissues existed individually in flowcytometric pattern, especially subcutaneous fat- and amniotic-derived cells showed the highest enrichment of CD73-positive cells.
[Scientific Reports] |
|
|
|
| Investigators report a case of myelodysplastic syndrome treated by umbilical cord blood transplantation after Mycobacterium kansasii pneumonia.
[Transplant Infectious Disease] |
|
|
|
|
| A wide variety of sources of therapeutic natural killer (NK) cells are currently being tested clinically, including haploidentical NK cells, umbilical cord blood NK cells, stem cell-derived NK cells, NK cell lines, adaptive NK cells, cytokine-induced memory-like NK cells and chimeric antigen receptor NK cells.The authors highlight the variety of ways in which diverse NK cell products and their auxiliary therapeutics are being leveraged to target human cancers.
[Nature Reviews Clinical Oncology] |
|
|
|
|
| The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells to treat children with Multisystem Inflammatory Syndrome in Children.
[Alliance for Cell Therapy Now (PR Newswire Association LLC.)] |
|
|
|
|
|
|
|
| | Purdue University – West Lafayette, Indiana, United States |
|
|
|
| | Myeloid Therapeutics – Cambridge, Massachusetts, United States |
|
|
|
| | University of Massachusetts – Amherst, Massachusetts, United States |
|
|
|
| | University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| | Huntington Medical Research Institutes – Pasadena, California, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
